IRWD,LNTH Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.21
Percentage change -4.66	%

Held by: IJR CALF VTI XBI VB IWM VXF VBK SPSM IBB

Index	RUT	P/E	99.54	EPS (ttm)	0.04	Insider Own	2.60%	Shs Outstand	156.35M	Perf Week	-5.91%
Market Cap	686.88M	Forward P/E	10.98	EPS next Y	0.39	Insider Trans	-5.46%	Shs Float	155.59M	Perf Month	-14.00%
Income	9.21M	PEG	-	EPS next Q	0.08	Inst Own	107.80%	Short Float	8.74%	Perf Quarter	-29.39%
Sales	400.56M	P/S	1.71	EPS this Y	104.01%	Inst Trans	-3.23%	Short Ratio	6.36	Perf Half Y	-52.38%
Book/sh	-2.01	P/B	-	EPS next Y	51.61%	ROA	1.84%	Short Interest	13.60M	Perf Year	-53.16%
Cash/sh	0.66	P/C	6.51	EPS next 5Y	-	ROE	-559.14%	52W Range	3.79 - 15.70	Perf YTD	-62.41%
Dividend Est.	-	P/FCF	4.69	EPS past 5Y	-28.37%	ROI	2.92%	52W High	-72.61%	Beta	0.49
Dividend TTM	-	Quick Ratio	3.92	Sales past 5Y	5.56%	Gross Margin	99.49%	52W Low	13.46%	ATR (14)	0.32
Dividend Ex-Date	-	Current Ratio	3.92	EPS Y/Y TTM	101.01%	Oper. Margin	32.83%	RSI (14)	39.32	Volatility	6.00% 6.58%
Employees	267	Debt/Eq	-	Sales Y/Y TTM	-6.25%	Profit Margin	2.30%	Recom	1.50	Target Price	12.12
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	99.92%	Payout	-	Rel Volume	3.30	Prev Close	4.51
Sales Surprise	-11.86%	EPS Surprise	-106.41%	Sales Q/Q	-12.09%	Earnings	Aug 08 BMO	Avg Volume	2.14M	Price	4.30
SMA20	-7.66%	SMA50	-20.62%	SMA200	-49.67%	Trades		Volume	7,065,745	Change	-4.66%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-24	Initiated	Leerink Partners	Market Perform	$5
Aug-08-24	Downgrade	CapitalOne	Overweight → Equal Weight	$12 → $4
Jan-17-24	Initiated	Craig Hallum	Buy	$21
Dec-14-23	Initiated	Wells Fargo	Overweight	$20
Nov-09-23	Initiated	Jefferies	Buy	$21
Sep-28-23	Initiated	JMP Securities	Mkt Outperform	$22
Sep-02-22	Initiated	CapitalOne	Overweight	$15
Apr-22-22	Initiated	Piper Sandler	Overweight	$16
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$14 → $9
Jun-17-20	Initiated	Northland Capital	Outperform	$14
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral	$14
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral
Jul-23-18	Initiated	H.C. Wainwright	Sell	$12.50
May-09-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jan-05-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-06-17	Downgrade	Mizuho	Buy → Neutral	$16

Show Previous Ratings

Sep-17-24 08:40AM	Implied Volatility Surging for Ironwood (IRWD) Stock Options (Zacks)
Sep-01-24 10:26PM	Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025? (Insider Monkey)
Aug-29-24 08:41PM	10 Best Multibagger Penny Stocks of 2025 (Insider Monkey) +7.58%
04:01PM	Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference (Business Wire)
Aug-09-24 10:56AM	Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates (Zacks)
08:15AM	Loading…
Aug-08-24 08:15AM	Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2 (Zacks) -32.61%
07:16AM	Ironwood: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Second Quarter 2024 Results (Business Wire)
Aug-01-24 10:01AM	Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q2 Earnings Expected to Decline (Zacks)
Jul-25-24 04:00PM	Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call (Business Wire)
Jul-17-24 08:30AM	Implied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock Options (Zacks)
Jul-08-24 07:00AM	Memo Therapeutics AG appoints Paul Carter as Chairperson (GlobeNewswire)
Jun-12-24 07:00PM	Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD) (GuruFocus.com) -6.27%
Jun-10-24 07:00PM	Insider Sale: Director Catherine Moukheibir Sells 80,000 Shares of Ironwood Pharmaceuticals Inc ... (GuruFocus.com)
May-30-24 04:01PM	Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference (Business Wire)
06:00AM	Loading…
May-21-24 06:00AM	Ironwood Late-Breaker Oral Presentation at Digestive Disease Week Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) (Business Wire) +5.61%
May-10-24 01:58PM	Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements (GuruFocus.com)
12:59PM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:16AM	Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates (Zacks)
May-09-24 03:59PM	Sector Update: Health Care Stocks Higher Late Afternoon (MT Newswires) -17.00%
01:55PM	Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading (MT Newswires)
01:39PM	Sector Update: Health Care (MT Newswires)
11:57AM	IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:54AM	Ironwood Pharmaceuticals' Shares Fall After Q1 Swings to a Non-GAAP Loss, Revenue Declines; 2024 Revenue Guidance Cut (MT Newswires)
07:11AM	Ironwood: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports First Quarter 2024 Results (Business Wire)
May-06-24 04:01PM	Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference (Business Wire)
May-02-24 02:33PM	Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management (Newsfile)
10:01AM	Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline (Zacks)
May-01-24 07:30AM	Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week 2024 (Business Wire) +6.06%
01:16PM	Loading…
Apr-30-24 01:16PM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Biotech Stocks (InvestorPlace)
Apr-25-24 04:01PM	Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call (Business Wire)
Apr-21-24 10:39AM	5 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Mar-28-24 07:30AM	Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD) (Business Wire)
Mar-05-24 01:05PM	Its Time! 3 Failing Biotech Stocks to Sell Right Now (InvestorPlace)
Feb-29-24 04:19PM	Ironwood Pharmaceuticals Ran Up 38% Over Three Months And Just Lost It All (Investor's Business Daily) -37.63%
08:37AM	Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? (InvestorPlace)
06:26AM	UPDATE 1-Ironwood's bowel disease treatment meets main goal in late-stage trial (Reuters)
06:08AM	Ironwood says bowel disease treatment meets main goal in late-stage trial (Reuters)
06:00AM	Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) (Business Wire)
Feb-23-24 07:30AM	Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference (Business Wire)
Feb-16-24 10:15AM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:36AM	Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally (Zacks)
Feb-15-24 10:45PM	Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:15AM	Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4 (Zacks)
07:26AM	Ironwood: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance (Business Wire)
Feb-05-24 08:50AM	Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Feb-01-24 04:01PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call (Business Wire)
Jan-23-24 09:55AM	Wall Street Analysts Think Ironwood (IRWD) Could Surge 37.6%: Read This Before Placing a Bet (Zacks)
Jan-08-24 07:00PM	Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation (Business Wire)
06:00AM	Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance (Business Wire)
Jan-03-24 04:01PM	Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-12-23 04:01PM	Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio (Business Wire)
Nov-30-23 09:45AM	Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management (Newsfile)
Nov-21-23 04:01PM	Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-10-23 02:45PM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:09AM	Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises (Zacks)
Nov-09-23 10:25PM	Q3 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:39AM	Ironwood Pharmaceuticals Inc (IRWD) Reports Growth in LINZESS Sales and Maintains Full Year Guidance (GuruFocus.com)
07:46AM	Top 11 Extreme Value Stocks To Buy (Insider Monkey)
07:22AM	Ironwood: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Third Quarter 2023 Results (Business Wire)
Oct-26-23 04:01PM	Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call (Business Wire)
Oct-23-23 07:30AM	Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting (Business Wire)
Oct-17-23 12:02PM	Decoding Ownership and Performance: Ironwood Pharmaceuticals Inc(IRWD) (GuruFocus.com)
Oct-16-23 06:00AM	Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week (Business Wire)
Oct-05-23 07:30AM	Ironwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old (Business Wire)
Oct-03-23 11:43AM	Ironwood Pharmaceuticals (IRWD): A Hidden Gem or a Potential Risk? An In-Depth Look at Its Valuation (GuruFocus.com)
Oct-01-23 07:15AM	Here's How to Lock in a Trade on a Promising Biopharma Name (TheStreet.com)
Sep-26-23 11:48AM	Unveiling Ironwood Pharmaceuticals (IRWD)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-20-23 07:36AM	Ironwood (IRWD) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
Sep-19-23 12:08PM	Ironwood Pharmaceuticals Inc (IRWD): A Deep Dive into Its Performance Potential (GuruFocus.com) +7.55%
11:39AM	Ironwood Pharmaceuticals (IRWD): A Comprehensive Analysis of Its Market Value (GuruFocus.com)
Sep-12-23 08:32AM	Implied Volatility Surging for Ironwood (IRWD) Stock Options (Zacks)
Sep-07-23 11:30AM	Why Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report? (Zacks)
Aug-12-23 08:50AM	Is There An Opportunity With Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) 49% Undervaluation? (Simply Wall St.)
Aug-09-23 09:24AM	Ironwood's (IRWD) Reports Q2 Loss, Linzess Volume Rises (Zacks) -6.79%
Aug-08-23 11:12PM	Q2 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -9.16%
11:05AM	Ironwood Pharmaceuticals (IRWD) Q2 Earnings and Revenues Surpass Estimates (Zacks)
09:56AM	Ironwood: Q2 Earnings Snapshot (AP Finance)
07:00AM	Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance (Business Wire)
Jul-28-23 02:56PM	10 Best Small Cap Pharma Stocks to Buy (Insider Monkey)
Jul-25-23 04:01PM	Ironwood Pharmaceuticals to Host Second Quarter 2023 Investor Update Call (Business Wire)
Jun-29-23 08:30AM	Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares (Business Wire)
Jun-21-23 08:00PM	IRWD: Lowering target price to $11.00 (Argus Research)
Jun-16-23 07:00AM	Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio (Business Wire)
Jun-13-23 09:18AM	Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion (Zacks)
Jun-12-23 04:05PM	Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old (Business Wire)
09:54AM	Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround (Motley Fool)
May-25-23 10:32AM	Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates (Zacks)
May-23-23 12:07PM	Ironwood (IRWD) to Acquire VectivBio for $1B, Stock Up 3.6% (Zacks)
May-22-23 05:43PM	Why Ironwood Pharmaceuticals Stock Bumped Higher Today (Motley Fool)
04:08PM	VectivBio Stock Catapults 39% After Ironwood Agrees To Buy It For $1 Billion (Investor's Business Daily)
01:11PM	Ironwood spends $1B to acquire Swiss biotech (American City Business Journals)
12:02PM	Why Shares of VectivBio Holding Are Up Today (Motley Fool)
08:40AM	Ironwood Pharmaceuticals to Buy VectivBio in $1 Billion Deal. The Sector Is Hot for M&A. (Barrons.com)
07:24AM	UPDATE 1-Ironwood Pharma to acquire VectivBio for $1.15 bln (Reuters)
07:22AM	Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy (Reuters)
06:57AM	Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases (Business Wire)

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
John Minardo	Chief Legal Officer	Aug 12 '24	Sale	4.27	9,910	42,316	284,661	Aug 14 05:10 PM
Silver Ronald	Principal Accounting Officer	Aug 12 '24	Sale	4.27	3,107	13,267	158,370	Aug 14 05:08 PM
John Minardo	Officer	Aug 12 '24	Proposed Sale	4.05	11,726	47,490		Aug 09 04:05 PM
McHugh Julie	Director	Jun 10 '24	Sale	6.29	22,766	143,198	139,528	Jun 12 04:05 PM
Moukheibir Catherine	Director	Jun 06 '24	Sale	6.36	44,426	282,549	84,207	Jun 10 04:58 PM
Moukheibir Catherine	Director	Jun 07 '24	Sale	6.61	35,574	235,144	48,633	Jun 10 04:58 PM
MCCOURT Thomas A	Chief Executive Officer	May 20 '24	Sale	6.45	67,618	436,136	1,150,330	May 22 04:05 PM
Davis Andrew	SVP, Chief Business Officer	May 20 '24	Sale	6.45	22,725	146,576	288,031	May 22 04:05 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	May 20 '24	Sale	6.45	16,128	104,026	413,719	May 22 04:05 PM
John Minardo	Chief Legal Officer	May 20 '24	Sale	6.45	17,404	112,256	294,571	May 22 04:05 PM
John Minardo	Chief Legal Officer	Mar 08 '24	Option Exercise	0.00	32,752	0	311,975	Mar 12 04:05 PM
Emany Sravan Kumar	SVP, Chief Financial Officer	Mar 08 '24	Option Exercise	0.00	37,120	0	338,853	Mar 12 04:05 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	Mar 08 '24	Option Exercise	0.00	34,936	0	429,847	Mar 12 04:05 PM
Davis Andrew	SVP, Chief Business Officer	Mar 08 '24	Option Exercise	0.00	37,120	0	310,756	Mar 12 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Mar 08 '24	Option Exercise	0.00	120,298	0	1,217,948	Mar 12 04:05 PM
Duane Jon R	Director	Mar 06 '24	Buy	8.70	6,920	60,204	121,028	Mar 08 04:05 PM
Emany Sravan Kumar	SVP, Chief Financial Officer	Mar 04 '24	Buy	9.38	10,684	100,216	301,733	Mar 06 04:05 PM
John Minardo	Chief Legal Officer	Feb 12 '24	Sale	15.24	47,380	722,071	224,796	Feb 14 09:01 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	Feb 12 '24	Sale	15.24	38,618	588,538	340,484	Feb 14 08:53 PM
Silver Ronald	Principal Accounting Officer	Feb 12 '24	Sale	15.24	7,908	120,518	134,264	Feb 14 08:50 PM
Davis Andrew	SVP, Chief Business Officer	Feb 12 '24	Sale	15.24	9,846	150,053	208,324	Feb 14 08:42 PM
MCCOURT Thomas A	Chief Executive Officer	Feb 12 '24	Sale	15.24	177,164	2,699,979	832,774	Feb 14 08:35 PM
Kessler Marla L	Director	Dec 14 '23	Sale	11.19	9,926	111,072	96,572	Dec 18 04:09 PM
Davis Andrew	SVP, Chief Business Officer	Nov 20 '23	Sale	9.69	3,287	31,851	217,374	Nov 22 04:05 PM

Dollar change +1.49
Percentage change 1.37	%

LNTH Lantheus Holdings Inc daily Stock Chart

Held by: IJH VTI IWM VB VXF VBK XMHQ IWO MDY IJK

Index	RUT	P/E	18.02	EPS (ttm)	6.11	Insider Own	2.53%	Shs Outstand	69.86M	Perf Week	4.26%
Market Cap	7.64B	Forward P/E	15.26	EPS next Y	7.21	Insider Trans	-4.46%	Shs Float	67.67M	Perf Month	8.72%
Income	428.48M	PEG	0.48	EPS next Q	1.56	Inst Own	99.25%	Short Float	6.28%	Perf Quarter	39.13%
Sales	1.44B	P/S	5.31	EPS this Y	6.98%	Inst Trans	-1.04%	Short Ratio	3.93	Perf Half Y	87.41%
Book/sh	14.51	P/B	7.58	EPS next Y	8.19%	ROA	26.15%	Short Interest	4.25M	Perf Year	77.61%
Cash/sh	10.90	P/C	10.09	EPS next 5Y	37.73%	ROE	54.26%	52W Range	50.20 - 126.89	Perf YTD	77.50%
Dividend Est.	-	P/FCF	19.35	EPS past 5Y	35.30%	ROI	26.06%	52W High	-13.27%	Beta	0.50
Dividend TTM	-	Quick Ratio	4.41	Sales past 5Y	36.54%	Gross Margin	64.49%	52W Low	119.22%	ATR (14)	4.10
Dividend Ex-Date	-	Current Ratio	4.68	EPS Y/Y TTM	1183.66%	Oper. Margin	31.47%	RSI (14)	61.73	Volatility	3.78% 4.03%
Employees	834	Debt/Eq	0.60	Sales Y/Y TTM	27.83%	Profit Margin	29.80%	Recom	1.17	Target Price	144.55
Option/Short	Yes / Yes	LT Debt/Eq	0.60	EPS Q/Q	-33.67%	Payout	0.00%	Rel Volume	1.07	Prev Close	108.56
Sales Surprise	3.13%	EPS Surprise	-1.62%	Sales Q/Q	22.50%	Earnings	Jul 31 BMO	Avg Volume	1.08M	Price	110.05
SMA20	4.47%	SMA50	3.70%	SMA200	43.12%	Trades		Volume	1,162,275	Change	1.37%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-24	Initiated	Redburn Atlantic	Buy	$175
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform	$100 → $130
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform	$100
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform	$120
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy	$105
May-09-22	Initiated	B. Riley Securities	Buy	$91
Apr-13-22	Initiated	Truist	Buy	$77
Feb-01-21	Initiated	SVB Leerink	Outperform	$24
Jun-29-20	Resumed	Jefferies	Buy	$29
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform	$6 → $12
Sep-23-16	Resumed	Credit Suisse	Neutral
Feb-24-16	Reiterated	RBC Capital Mkts	Outperform	$9 → $6
Dec-11-15	Downgrade	Credit Suisse	Outperform → Neutral
Sep-30-15	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-20-15	Initiated	Wells Fargo	Outperform

Show Previous Ratings

Sep-19-24 12:08PM	Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players (PR Newswire)
Sep-15-24 08:45AM	Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 (GlobeNewswire)
Sep-05-24 08:30AM	Lantheus Appoints Julie Eastland as New Board Member (GlobeNewswire)
Aug-28-24 08:30AM	Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-20-24 08:30AM	Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 (GlobeNewswire)
07:01PM	Loading…
Aug-14-24 07:01PM	Insider Sale: Director Gerard Ber Sells 15,500 Shares of Lantheus Holdings Inc (LNTH) (GuruFocus.com)
Jul-31-24 07:13AM	Lantheus Holdings: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Lantheus Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-23-24 03:52AM	Nanotechnology in medicine: Who are the leading public companies? (Medical Device Network)
Jul-17-24 08:30AM	Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time (GlobeNewswire)
Jul-15-24 08:30AM	Lantheus Acquires NAV-4694, a Next-Generation Amyloid PET Imaging Agent for Alzheimer's Disease (GlobeNewswire)
Jul-10-24 04:11PM	Lantheus Stock Gets A Radioactive Surge On Medicare Proposal (Investor's Business Daily) +36.65% +16.42%
12:32PM	Lantheus Welcomes CMS' Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access (GlobeNewswire)
11:57AM	Why Lantheus Holdings Stock Is Skyrocketing Today (Motley Fool)
Jul-08-24 08:30AM	Lantheus Appoints Jamie Spaeth as Chief People Officer (GlobeNewswire)
06:48AM	Loading…
Jul-05-24 06:48AM	Is Lantheus Holdings Inc (NASDAQ:LNTH) the Best Jim Cramer Stock in 2024? (Insider Monkey)
Jul-04-24 07:47AM	Jim Cramer's Latest Stock Portfolio: Top 10 Recommendations (Insider Monkey)
Jun-27-24 07:05AM	Lantheus Acquires Global Rights to Life Molecular Imaging's Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers (GlobeNewswire)
Jun-24-24 09:50AM	Why Lantheus Holdings (LNTH) is a Top Momentum Stock for the Long-Term (Zacks)
Jun-20-24 08:41PM	Radiopharm Receives Strategic Investment for up to A$18 million (GlobeNewswire)
Jun-18-24 06:15PM	Lantheus Holdings (LNTH) Stock Sinks As Market Gains: What You Should Know (Zacks)
11:47AM	Lantheus (LNTH) Gains 33.3% YTD: What's Driving the Stock? (Zacks)
Jun-10-24 06:15PM	Lantheus Holdings (LNTH) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Jun-03-24 08:30AM	Lantheus' AI-Enabled aPROMISE Now Available on Siemens Healthineers' syngo.via platform (GlobeNewswire)
May-31-24 12:00PM	Lantheus Holdings (LNTH) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
May-30-24 07:00PM	Director Heinz Maeusli Sells 18,373 Shares of Lantheus Holdings Inc (LNTH) (GuruFocus.com)
07:00PM	Insider Selling: Director Julie Mchugh Sells Shares of Lantheus Holdings Inc (LNTH) (GuruFocus.com)
11:55AM	Here's Why You Should Add Lantheus (LNTH) to Your Portfolio Now (Zacks)
May-28-24 09:40AM	Are Medical Stocks Lagging Lantheus (LNTH) This Year? (Zacks)
08:00AM	Lantheus to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire)
12:45PM	Loading…
May-27-24 12:45PM	Is Lantheus Holdings (LNTH) a Solid Growth Stock? 3 Reasons to Think 'Yes' (Zacks)
09:55AM	Wall Street Analysts Believe Lantheus Holdings (LNTH) Could Rally 31.21%: Here's is How to Trade (Zacks)
May-24-24 09:45AM	Here's Why Lantheus Holdings (LNTH) is a Strong Growth Stock (Zacks)
May-20-24 09:00AM	Investors Heavily Search Lantheus Holdings, Inc. (LNTH): Here is What You Need to Know (Zacks)
May-15-24 04:30PM	Lantheus Announces Executive Appointments to Accelerate Innovation (GlobeNewswire)
07:00AM	Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results (GlobeNewswire)
May-07-24 09:00AM	Here is What to Know Beyond Why Lantheus Holdings, Inc. (LNTH) is a Trending Stock (Zacks)
May-03-24 12:36PM	Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:24PM	Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up (Zacks)
09:31AM	Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating (MT Newswires)
03:04AM	Lantheus Holdings Inc (LNTH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
May-02-24 11:14AM	Lantheus Shares Rise After Reporting Higher Q1 Adjusted Earnings, Revenue; 2024 Guidance Raised (MT Newswires) +16.01%
10:30AM	Lantheus Holdings (LNTH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:14AM	Lantheus Holdings Inc (LNTH) Surpasses Q1 2024 Revenue and Earnings Estimates (GuruFocus.com)
08:35AM	Lantheus Holdings (LNTH) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:32AM	Lantheus Holdings: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Lantheus Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-30-24 02:39PM	Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now (Zacks)
Apr-26-24 05:50PM	Here's Why Lantheus Holdings (LNTH) Gained But Lagged the Market Today (Zacks)
01:12PM	Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings (Zacks)
Apr-25-24 10:01AM	Lantheus Holdings (LNTH) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-24-24 06:00PM	Lantheus Holdings (LNTH) Outpaces Stock Market Gains: What You Should Know (Zacks)
09:00AM	Lantheus Holdings, Inc. (LNTH) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-23-24 09:45AM	Why Lantheus Holdings (LNTH) is a Top Growth Stock for the Long-Term (Zacks)
09:40AM	Is Lantheus (LNTH) Stock Undervalued Right Now? (Zacks)
Apr-19-24 12:10PM	Will Lantheus Holdings (LNTH) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-18-24 08:00AM	Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time (GlobeNewswire)
Apr-15-24 06:00PM	Lantheus Holdings (LNTH) Stock Moves -0.89%: What You Should Know (Zacks)
09:50AM	Here's Why Lantheus Holdings (LNTH) is a Strong Momentum Stock (Zacks)
Apr-13-24 12:12PM	10 Most Undervalued Value Stocks To Buy Now (Insider Monkey)
Apr-11-24 09:00AM	Lantheus Holdings, Inc. (LNTH) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Apr-10-24 02:18PM	Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024 (InvestorPlace)
Apr-09-24 06:00PM	Lantheus Holdings (LNTH) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Apr-05-24 09:00AM	Is Trending Stock Lantheus Holdings, Inc. (LNTH) a Buy Now? (Zacks)
Apr-03-24 05:45PM	Lantheus Holdings (LNTH) Exceeds Market Returns: Some Facts to Consider (Zacks)
Mar-28-24 10:04AM	Here's Why You Should Add Lantheus (LNTH) to Your Portfolio (Zacks)
07:30AM	Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results (GlobeNewswire)
Mar-26-24 05:45PM	Lantheus Holdings (LNTH) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Mar-25-24 09:00AM	Is Most-Watched Stock Lantheus Holdings, Inc. (LNTH) Worth Betting on Now? (Zacks)
Mar-22-24 09:30AM	Lantheus (LNTH) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Mar-20-24 05:45PM	Why Lantheus Holdings (LNTH) Outpaced the Stock Market Today (Zacks)
Mar-14-24 05:45PM	Lantheus Holdings (LNTH) Rises As Market Takes a Dip: Key Facts (Zacks)
09:50AM	Why Lantheus Holdings (LNTH) is a Top Momentum Stock for the Long-Term (Zacks)
Mar-13-24 04:30PM	The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024 (InvestorPlace)
Mar-12-24 09:00AM	Lantheus Holdings, Inc. (LNTH) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-11-24 07:01PM	Insider Sell: President Paul Blanchfield Sells Shares of Lantheus Holdings Inc (LNTH) (GuruFocus.com)
Mar-08-24 05:45PM	Lantheus Holdings (LNTH) Stock Moves -0.11%: What You Should Know (Zacks)
03:00AM	Director Sam Leno Sells Shares of Lantheus Holdings Inc (LNTH) (GuruFocus.com)
Mar-07-24 09:40AM	Is Lantheus (LNTH) a Great Value Stock Right Now? (Zacks)
Mar-06-24 09:55AM	Wall Street Analysts See a 44.13% Upside in Lantheus Holdings (LNTH): Can the Stock Really Move This High? (Zacks)
09:30AM	Wall Street Analysts See Lantheus Holdings (LNTH) as a Buy: Should You Invest? (Zacks)
Mar-05-24 10:15AM	Lantheus' (LNTH) DEFINITY Approved by FDA for Pediatric Use (Zacks)
08:30AM	Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024 (GlobeNewswire)
08:00AM	Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility (GlobeNewswire)
Mar-04-24 08:30AM	Lantheus Announces the FDA Approval of DEFINITY (Perflutren Lipid Microsphere) for Pediatric Patients (GlobeNewswire)
Feb-28-24 08:30AM	Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer (GlobeNewswire)
Feb-27-24 09:00AM	Lantheus Holdings, Inc. (LNTH) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Feb-26-24 11:00AM	Here's Why You Should Add Lantheus (LNTH) to Your Portfolio (Zacks)
08:30AM	Lantheus to Present at the TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-23-24 11:00AM	Lantheus (LNTH) Q4 Earnings Surpass Estimates, Gross Margin Up (Zacks)
10:48AM	Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:30AM	Lantheus Holdings (LNTH) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Feb-22-24 09:30AM	Lantheus Holdings (LNTH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +14.71%
08:30AM	Lantheus Holdings (LNTH) Q4 Earnings and Revenues Beat Estimates (Zacks)
08:12AM	Lantheus Holdings Inc Reports Robust Revenue Growth and Strong Earnings in Q4 and Full Year 2023 (GuruFocus.com)
07:33AM	Lantheus Holdings: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
03:55AM	11 Best Small-Cap Growth Stocks to Invest In (Insider Monkey)
Feb-19-24 09:55AM	Wall Street Analysts Think Lantheus Holdings (LNTH) Could Surge 58.6%: Read This Before Placing a Bet (Zacks)
09:30AM	Should You Invest in Lantheus Holdings (LNTH) Based on Bullish Wall Street Views? (Zacks)

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sabens Andrea	Officer	Sep 13 '24	Proposed Sale	104.10	341	35,498		Sep 13 01:29 PM
Thrall James H	Director	Aug 21 '24	Sale	98.52	1,000	98,520	34,207	Aug 23 04:30 PM
Thrall James H	Director	Aug 21 '24	Proposed Sale	98.52	1,000	98,520		Aug 21 09:51 AM
Niedzwiecki Daniel	See Remarks	Aug 14 '24	Sale	97.54	2,500	243,850	77,744	Aug 16 04:30 PM
Ber Gerard	Director	Aug 12 '24	Sale	96.48	15,500	1,495,396	21,221	Aug 14 04:56 PM
Niedzwiecki Daniel	Officer	Aug 14 '24	Proposed Sale	97.54	2,500	243,850		Aug 14 12:41 PM
Sabens Andrea	Officer	Aug 13 '24	Proposed Sale	97.83	341	33,360		Aug 13 10:59 AM
Blanchfield Paul	President	Aug 08 '24	Sale	96.39	2,000	192,780	98,980	Aug 12 05:09 PM
Gerard Ber	Director	Aug 12 '24	Proposed Sale	97.33	15,500	1,508,615		Aug 12 04:23 PM
Blanchfield Paul	Officer	Aug 08 '24	Proposed Sale	96.39	2,000	192,780		Aug 08 11:16 AM
Heino Mary Anne	Director	Aug 02 '24	Sale	95.50	10,481	1,000,900	454,923	Aug 06 04:30 PM
Heino Mary Anne	Officer	Aug 02 '24	Proposed Sale	95.42	10,481	1,000,115		Aug 02 04:21 PM
Sabens Andrea	Chief Accounting Officer	Jul 16 '24	Sale	124.96	1,796	224,423	60,420	Jul 17 04:30 PM
Sabens Andrea	Chief Accounting Officer	Jul 15 '24	Sale	123.15	341	41,994	62,216	Jul 17 04:30 PM
Pruden Gary J	Director	Jul 10 '24	Sale	95.04	12,530	1,190,851	11,978	Jul 12 04:30 PM
Sabens Andrea	Chief Accounting Officer	Jun 13 '24	Sale	79.77	341	27,202	62,557	Jun 17 04:30 PM
Blanchfield Paul	President	May 31 '24	Sale	80.82	1,179	95,287	101,498	Jun 04 04:30 PM
Niedzwiecki Daniel	See Remarks	May 30 '24	Sale	79.86	12,873	1,028,038	80,244	Jun 03 04:30 PM
Maeusli Heinz Christoph	Director	May 28 '24	Option Exercise	16.17	17,481	282,668	49,032	May 30 04:34 PM
Maeusli Heinz Christoph	Director	May 28 '24	Sale	79.19	18,373	1,454,989	23,340	May 30 04:34 PM
McHugh Julie	Director	May 28 '24	Sale	78.50	2,500	196,250	28,617	May 30 04:32 PM
Sabens Andrea	Chief Accounting Officer	May 13 '24	Sale	76.89	341	26,219	62,898	May 15 05:09 PM
Sabens Andrea	Chief Accounting Officer	Apr 15 '24	Sale	61.24	341	20,883	63,239	Apr 17 04:30 PM
Marshall Robert J. Jr.	CFO and Treasurer	Mar 15 '24	Sale	60.00	20,000	1,200,000	113,749	Mar 19 04:30 PM
Sabens Andrea	Chief Accounting Officer	Mar 13 '24	Sale	60.48	341	20,624	63,204	Mar 15 04:30 PM
Blanchfield Paul	President	Mar 07 '24	Sale	61.96	18,023	1,116,705	103,357	Mar 11 04:30 PM
Lantheus Alpha Therapy, LLC	10% Owner	Mar 06 '24	Buy	0.95	60,431,039	57,409,487	116,773,394	Mar 08 11:24 AM
LENO SAM R	Director	Mar 05 '24	Option Exercise	16.30	2,045	33,334	59,982	Mar 07 04:30 PM
LENO SAM R	Director	Mar 06 '24	Option Exercise	16.30	2,045	33,334	59,982	Mar 07 04:30 PM
LENO SAM R	Director	Mar 05 '24	Sale	64.62	2,045	132,148	57,937	Mar 07 04:30 PM
LENO SAM R	Director	Mar 06 '24	Sale	63.50	2,045	129,857	57,937	Mar 07 04:30 PM
LENO SAM R	Director	Mar 04 '24	Option Exercise	19.85	22,389	444,499	80,326	Mar 06 05:15 PM
LENO SAM R	Director	Mar 04 '24	Sale	65.42	22,389	1,464,749	57,937	Mar 06 05:15 PM
Heino Mary Anne	Director	Mar 04 '24	Sale	65.31	93,863	6,129,889	251,643	Mar 05 08:28 PM
Sabens Andrea	Chief Accounting Officer	Feb 13 '24	Sale	55.31	341	18,861	58,403	Feb 15 04:30 PM
Sabens Andrea	Chief Accounting Officer	Jan 16 '24	Sale	56.01	341	19,099	58,744	Jan 18 04:30 PM
Marshall Robert J. Jr.	CFO and Treasurer	Dec 15 '23	Sale	78.24	10,000	782,400	103,170	Dec 19 05:00 PM
Sabens Andrea	Chief Accounting Officer	Dec 13 '23	Sale	75.62	341	25,786	59,085	Dec 15 04:30 PM
Blanchfield Paul	President	Nov 16 '23	Sale	67.96	1,500	101,940	88,651	Nov 20 04:30 PM
Heino Mary Anne	CEO	Nov 13 '23	Sale	63.72	11,780	750,611	317,687	Nov 15 04:32 PM
Sabens Andrea	Chief Accounting Officer	Nov 13 '23	Sale	63.57	341	21,677	59,426	Nov 15 04:30 PM

IRWD

Ironwood Pharmaceuticals Inc

LNTH

Lantheus Holdings Inc

Upgrade your FINVIZ experience